Li Zhang

5PUBLICATIONS

38CO-AUTHORS

Cancer geneticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseases

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|May 29, 2026

Alcohol-Induced Metabolic Stress Sensed by m6A-Modified ChREBP Drives Immune Evasion in Esophageal Carcinogenesis.

|Feb 26, 2026

A Circulating GPNMB-Based Multimodal Model Integrates Tumor-Immune Crosstalk to Predict Immunotherapy Response in Esophageal Cancer.

Liang Zhu, Xiaoyuan Wang, Guoyu Cheng

|Jun 18, 2025

Clinical efficacy and biomarkers of neoadjuvant chemoimmunotherapy in locally advanced esophageal squamous cell carcinoma.

Siyou Deng, Qi Wang, Yueping Li

|Dec 02, 2021

GTF2E2 is a novel biomarker for recurrence after surgery and promotes progression of esophageal squamous cell carcinoma via miR-139-5p/GTF2E2/FUS axis.

Yujie Zhang, Yuxin Zhang, Bo Ai

|Dec 10, 2020

Repurposed Tocilizumab in Patients with Severe COVID-19.

Jianbo Tian, Ming Zhang, Meng Jin

Pageof 1

Frequent Collaborators

Jiang Chang

Jianbo Tian

Ke Hu

Xiaoping Miao

Huilan Zhang

Yujie Zhang

Shiying Yu

Xiuyu Cai

Liang Zhu

Xiaoyuan Wang

Frequent Collaborators

Jiang Chang

Jianbo Tian

Ke Hu

Xiaoping Miao